Argenx Se ARGX
NASDAQ ARGX
$962.22 +16.40 (+1.73%)
At close: Sep 24, 2026 · 4:00 PM EDT

Argenx Se (ARGX) Current Deferred Revenue (2015 - 2020)

Argenx Se's (ARGX) quarterly Current Deferred Revenue came in at $45.0 billion in Q4 2020, up 56117.92% on a YoY basis from N/an in Q1 2020, and up 60629.5% quarter-over-quarter from $74.1 million in Q2 2020.

Analysis

Argenx Se (ARGX) Current Deferred Revenue (2015 - 2020) Analysis & Trends

Argenx Se (ARGX) has reported Current Deferred Revenue for 6 consecutive years, with $45.0 billion the latest figure, recorded in Q4 2020.

  • For the quarter ending Q4 2020, Current Deferred Revenue rose 56117.92% year-over-year to $45.0 billion; the trailing twelve-month figure through Dec 2020 stood at $45.0 billion (up 56117.92% YoY), and the FY2020 full-year result was $269.0 billion, up 231.06% from the prior year.
  • Current Deferred Revenue advanced to $45.0 billion in Q4 2020 per ARGX's latest filing, from $74.1 million in the prior quarter.
  • Across five years, Current Deferred Revenue topped out at $45.0 billion in Q4 2020 and bottomed at $2.5 million in Q4 2018.
  • Historically, Current Deferred Revenue has averaged $5.0 billion across 5 years, with a median of $23.7 million in 2017.
  • The sharpest annual moves came in 2018 and 2020: Current Deferred Revenue sank 83.53% in 2018, then surged 56117.92% in 2020.
  • Over 5 years, Current Deferred Revenue stood at $21.7 million in 2016, then plunged by 31.11% to $15.0 million in 2017, then plunged by 83.53% to $2.5 million in 2018, then jumped by 3146.23% to $80.1 million in 2019, then soared by 56117.92% to $45.0 billion in 2020.
  • According to Business Quant data, Current Deferred Revenue over the past three periods registered $45.0 billion, $74.1 million, and $80.1 million for Q4 2020, Q2 2020, and Q4 2019 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 649.01 Bn 628.25 Bn 17.26 Bn
2 AbbVie 468.55 Bn 462.03 Bn 12.70 Bn
3 Merck 365.49 Bn 358.40 Bn 12.21 Bn
4 Novartis Ag 272.39 Bn 265.10 Bn 11.24 Bn
5 Astrazeneca 253.18 Bn 247.96 Bn 12.86 Bn
6 Amgen 219.53 Bn 205.54 Bn 7.24 Bn
7 Gilead Sciences 187.85 Bn 184.59 Bn 6.22 Bn
8 Pfizer 160.56 Bn 149.16 Bn 10.94 Bn
9 Vertex Pharmaceuticals 130.81 Bn 122.96 Bn 2.84 Bn
10 Argenx Se 58.53 Bn 53.35 Bn 1.37 Bn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 45.01 Bn
Jun 30, 2020 74.12 Mn
Dec 31, 2019 80.07 Mn
Jun 30, 2019 51.53 Mn
Dec 31, 2018 2.47 Mn
Jun 30, 2018 5.86 Mn
Dec 31, 2017 14.98 Mn
Jun 30, 2017 23.72 Mn
Dec 31, 2016 21.74 Mn
Dec 31, 2015 4.54 Mn
API Access

Argenx Se Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=ARGX&period=max&api_key=YOUR_API_KEY